Aarti Drugs shares skyrocket over 19% on Q1 results and buyback announcement
Further, the board has approved a buyback not exceeding 6,65,000 lakh equity shares for an amount not exceeding Rs 59.85 crore. The buyback price is fixed at Rs 900 per equity share, which is a 76% premium from the last closing price.